# HEDN: A Hard-Easy Dual Network with Source Reliability Assessment for Cross-Subject EEG Emotion Recognition

Preprint · Qiang Wang, Liying Yang, Jiayun Song, Yifan Bai, Jingtao Du

- Archive id: arxiv:2511.06782
- Published: 2025-11-10
- arXiv: https://arxiv.org/abs/2511.06782
- Source URL: https://arxiv.org/abs/2511.06782
- PDF: https://arxiv.org/pdf/2511.06782
- Provenance: arxiv

## Abstract

Cross-subject electroencephalography (EEG) emotion recognition remains a major challenge in brain-computer interfaces (BCIs) due to substantial inter-subject variability. Multi-Source Domain Adaptation (MSDA) offers a potential solution, but existing MSDA frameworks typically assume equal source quality, leading to negative transfer from low-reliability domains and prohibitive computational overhead due to multi-branch model designs. To address these limitations, we propose the Hard-Easy Dual Network (HEDN), a lightweight reliability-aware MSDA framework. HEDN introduces a novel Source Reliability Assessment (SRA) mechanism that dynamically evaluates the structural integrity of each source domain during training. Based on this assessment, sources are routed to two specialized branches: an Easy Network that exploits high-quality sources to construct fine-grained, structure-aware prototypes for reliable pseudo-label generation, and a Hard Network that utilizes adversarial training to refine and align low-quality sources. Furthermore, a cross-network consistency loss aligns predictions between branches to preserve semantic coherence. Extensive experiments conducted on SEED, SEED-IV, and DEAP datasets demonstrate that HEDN achieves state-of-the-art performance across both cross-subject and cross-dataset evaluation protocols while reducing adaptation complexity.

_Abstract reproduced under CC0-1.0 (arXiv descriptive metadata)._

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.